Sonoma Pharmaceuticals Inc (SNOA) — Capital Reinvestment Ratio
Sonoma Pharmaceuticals Inc (SNOA) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($565.00K) in capital expenditures ($2.00K). Check Sonoma Pharmaceuticals Inc (SNOA) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sonoma Pharmaceuticals Inc Capital Reinvestment Ratio (2013–2013)
This chart tracks Sonoma Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Sonoma Pharmaceuticals Inc (SNOA) cash flow conversion.
Annual Capital Reinvestment Ratio for Sonoma Pharmaceuticals Inc (2013–2013)
Year-by-year Capital Reinvestment Ratio for Sonoma Pharmaceuticals Inc from 2013 to 2013. See how much free cash does Sonoma Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.22x | $1.15 Million | $257.00K | — |